Publicacions en què col·labora amb Marçal Pastor Anglada (12)

2015

  1. Fluorescent nucleoside derivatives as a tool for the detection of concentrative nucleoside transporter activity using confocal microscopy and flow cytometry

    Molecular Pharmaceutics, Vol. 12, Núm. 6, pp. 2158-2166

2012

  1. Functional analysis of the human concentrative nucleoside transporter-1 variant hCNT1S546P provides insight into the sodium-binding pocket

    American Journal of Physiology - Cell Physiology, Vol. 302, Núm. 1

2010

  1. Effects of Na+ and H+ on steady-state and presteady-state currents of the human concentrative nucleoside transporter 3 (hCNT3)

    Pflugers Archiv European Journal of Physiology, Vol. 460, Núm. 3, pp. 617-632

  2. Erratum: Effects of Na+ and H+ on steady-state and presteady-state currents of the human concentrative nucleoside transporter 3 (hCNT3) (Pflugers Archiv European Journal of Physiology DOI: 10.1007/s00424-010-0846-9)

    Pflugers Archiv European Journal of Physiology

2008

  1. Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells

    Biochemical Pharmacology, Vol. 75, Núm. 3, pp. 639-648

2005

  1. Cell entry and export of nucleoside analogues

    Virus Research, Vol. 107, Núm. 2, pp. 151-164

2004

  1. Electrophysiological Characterization of the Human Na +/Nucleoside Cotransporter 1 (hCNT1) and Role of Adenosine on hCNT1 Function

    Journal of Biological Chemistry, Vol. 279, Núm. 10, pp. 8999-9007

  2. Erratum: Electrophysiological characterization of the human Na +/nucleoside cotransporter 1 (hCNT1) and role of adenosine on hCNT1 function (The Journal of Biological Chemistry (2004) 279 (8999-9007))

    Journal of Biological Chemistry

  3. Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1)

    Antiviral Therapy, Vol. 9, Núm. 6, pp. 993-1002

2002

  1. Nucleoside transporters in absorptive epithelia

    Journal of Physiology and Biochemistry

2001

  1. Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug

    Molecular Pharmacology, Vol. 59, Núm. 6, pp. 1542-1548

2000

  1. Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes

    FEBS Letters, Vol. 481, Núm. 2, pp. 137-140